| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Faraz Sachedina, Carole Chan, Rahim S Damji, Olga J de Sancti. Medical cannabis use in Canada and its impact on anxiety and depression: A retrospective study. Psychiatry research. vol 313. 2022-05-22. PMID:35598566. |
this was a retrospective study of patients utilizing medical cannabis who received their medical cannabis documentation and allotment from a harvest medicine clinic in canada to determine the impact of medical cannabis on anxiety and depression outcomes. |
2022-05-22 |
2023-08-13 |
Not clear |
| Faraz Sachedina, Carole Chan, Rahim S Damji, Olga J de Sancti. Medical cannabis use in Canada and its impact on anxiety and depression: A retrospective study. Psychiatry research. vol 313. 2022-05-22. PMID:35598566. |
there were statistically significant improvements between baseline and follow-up scores for both the gad-7 and phq-9, with larger improvements seen for patients who were actively seeking medical cannabis to treat anxiety or depression. |
2022-05-22 |
2023-08-13 |
Not clear |
| Faraz Sachedina, Carole Chan, Rahim S Damji, Olga J de Sancti. Medical cannabis use in Canada and its impact on anxiety and depression: A retrospective study. Psychiatry research. vol 313. 2022-05-22. PMID:35598566. |
this study provides some evidence to support the effectiveness of medical cannabis as a treatment for anxiety and depression. |
2022-05-22 |
2023-08-13 |
Not clear |
| Nirushi Kuhathasan, Luciano Minuzzi, James MacKillop, Benicio N Fre. An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample. BMC psychiatry. vol 22. issue 1. 2022-04-28. PMID:35484520. |
an investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample. |
2022-04-28 |
2023-08-13 |
Not clear |
| Nirushi Kuhathasan, Luciano Minuzzi, James MacKillop, Benicio N Fre. An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample. BMC psychiatry. vol 22. issue 1. 2022-04-28. PMID:35484520. |
little is known about cannabis use for insomnia in individuals with depression, anxiety, and comorbid depression and anxiety. |
2022-04-28 |
2023-08-13 |
Not clear |
| Matthias Hans Belau, Christian Wiessner, Heiko Becher, Ursula von Rüden, Peer Brike. Frequent Cannabis Use Moderates the Relationship Between Sexual Dysfunction and Depression Among Female German Adults. The journal of sexual medicine. 2022-04-18. PMID:35431149. |
frequent cannabis use moderates the relationship between sexual dysfunction and depression among female german adults. |
2022-04-18 |
2023-08-13 |
Not clear |
| Nadia Saadat, Liying Zhang, Suzanne Hyer, Vasantha Padmanabhan, Jennifer Woo, Christopher G Engeland, Dawn P Misra, Carmen Giurgesc. Psychosocial and behavioral factors affecting inflammation among pregnant African American women. Brain, behavior, & immunity - health. vol 22. 2022-04-11. PMID:35403067. |
twenty-six percent of women had center for epidemiological studies-depression (ces-d) scores ≥23 (scores that have been correlated with clinical diagnosis of depression), 15.5% smoked cigarettes, 16.6% used marijuana, and 5.3% reported experiencing intimate partner violence (ipv). |
2022-04-11 |
2023-08-13 |
Not clear |
| Gniewko Wieckiewicz, Iga Stokłosa, Maciej Stokłosa, Piotr Gorczyca, Robert Pudl. Cannabidiol (CBD) in the Self-Treatment of Depression-Exploratory Study and a New Phenomenon of Concern for Psychiatrists. Frontiers in psychiatry. vol 13. 2022-04-08. PMID:35392393. |
one of these substances is cannabidiol (cbd), which has gained widespread popularity on the internet as a cure for mental health problems, leading many people to use cbd to self-treat depression and anxiety. |
2022-04-08 |
2023-08-13 |
Not clear |
| Sharlene D Newma. Association Between Hormonal Birth Control, Substance Use, and Depression. Frontiers in psychiatry. vol 13. 2022-02-25. PMID:35211041. |
the current study examined the impact of the use of hormonal birth control, cannabis (cb), and alcohol on depression symptoms. |
2022-02-25 |
2023-08-13 |
Not clear |
| Ming Hou, Suji Wang, Dandan Yu, Xinyi Lu, Xiansen Zhao, Zhangpeng Chen, Chao Ya. Cannabidiol prevents depressive-like behaviors through the modulation of neural stem cell differentiation. Frontiers of medicine. 2022-02-25. PMID:35212887. |
the nonpsychoactive phytocannabinoid cannabidiol (cbd) has been shown to be effective against depression. |
2022-02-25 |
2023-08-13 |
mouse |
| Dorothy Wallis, J Douglas Coatsworth, Jeremy Mennis, Nathaniel R Riggs, Nikola Zaharakis, Michael A Russell, Aaron R Brown, Stephanie Rayburn, Aubrie Radford, Christopher Hale, Michael J Maso. Predicting Self-Medication with Cannabis in Young Adults with Hazardous Cannabis Use. International journal of environmental research and public health. vol 19. issue 3. 2022-02-15. PMID:35162872. |
participants living where cannabis is legal were less likely to self-medicate for anxiety and depression. |
2022-02-15 |
2023-08-13 |
human |
| Aslesha Sumbe, Anna V Wilkinson, Stephanie L Clendennen, Bara S Bataineh, Kymberle L Sterling, Baojiang Chen, Melissa B Harrel. Association of tobacco and marijuana use with symptoms of depression and anxiety among adolescents and young adults in Texas. Tobacco prevention & cessation. vol 8. 2022-02-07. PMID:35128214. |
young people with depression and/or anxiety may self-medicate with tobacco or tobacco with marijuana to reduce their symptoms. |
2022-02-07 |
2023-08-13 |
Not clear |
| Aslesha Sumbe, Anna V Wilkinson, Stephanie L Clendennen, Bara S Bataineh, Kymberle L Sterling, Baojiang Chen, Melissa B Harrel. Association of tobacco and marijuana use with symptoms of depression and anxiety among adolescents and young adults in Texas. Tobacco prevention & cessation. vol 8. 2022-02-07. PMID:35128214. |
this study sought to differentiate between the use of tobacco products as intended and tobacco products modified to accommodate marijuana, and to explore their relationships with symptoms of depression and anxiety among youth and young adults. |
2022-02-07 |
2023-08-13 |
Not clear |
| Kate Wolitzky-Taylor, Suzette Glasner, Alexandra Tanner, Dara G Ghahremani, Edythe D Londo. Targeting maladaptive reactivity to negative affect in emerging adults with cannabis use disorder: A preliminary test and proof of concept. Behaviour research and therapy. vol 150. 2022-01-15. PMID:35032700. |
cannabis use disorder (cud) is a growing public health concern, and is highly comorbid with negative affective conditions such as anxiety and depression. |
2022-01-15 |
2023-08-13 |
Not clear |
| Matthew E Hirschtritt, Lyndsay A Avalos, Varada Sarovar, Kathryn K Ridout, Nancy C Goler, Deborah R Ansley, Derek D Satre, Kelly C Young-Wolf. Association Between Prenatal Cannabis Use and Psychotropic Medication Use in Pregnant Patients With Depression and Anxiety. Journal of addiction medicine. 2022-01-12. PMID:35020701. |
association between prenatal cannabis use and psychotropic medication use in pregnant patients with depression and anxiety. |
2022-01-12 |
2023-08-13 |
Not clear |
| Matthew E Hirschtritt, Lyndsay A Avalos, Varada Sarovar, Kathryn K Ridout, Nancy C Goler, Deborah R Ansley, Derek D Satre, Kelly C Young-Wolf. Association Between Prenatal Cannabis Use and Psychotropic Medication Use in Pregnant Patients With Depression and Anxiety. Journal of addiction medicine. 2022-01-12. PMID:35020701. |
this cross-sectional study examined associations between prenatal cannabis use and prescribed psychotropic medication use among pregnant patients with depression or anxiety in a large, integrated healthcare system. |
2022-01-12 |
2023-08-13 |
Not clear |
| Lijuan Ma, Shuang Wu, Kai Zhang, Mei Tian, Hong Zhan. Progress on the application of positron emission tomography imaging of cannabinoid type 1 receptor in neuropsychiatric diseases. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences. vol 50. issue 5. 2022-01-05. PMID:34986538. |
this article reviews the application of cb1r pet imaging in alzheimer's disease, parkinson's disease, huntington's disease, schizophrenia, post-traumatic stress disorder, cannabis use disorder and depression. |
2022-01-05 |
2023-08-13 |
Not clear |
| Ana Martín-Sánchez, Héctor González-Pardo, Laia Alegre-Zurano, Adriana Castro-Zavala, Isabel López-Taboada, Olga Valverde, Nélida M Conej. Early-life stress induces emotional and molecular alterations in female mice that are partially reversed by cannabidiol. Progress in neuro-psychopharmacology & biological psychiatry. 2022-01-01. PMID:34973413. |
in the present study, we summarize findings describing cannabidiol effects on anxiety and depression in maternally separated female mice as a well-established rodent model of early-life stress associated with many mental disorders. |
2022-01-01 |
2023-08-13 |
mouse |
| Paulo Rogério Morais, Kelsy Catherina Nema Areco, Thiago Marques Fidalgo, Dartiu Xavier da Silveir. Mental health and quality of life in a population of recreative cannabis users in Brazil. Journal of psychiatric research. vol 146. 2021-12-22. PMID:34936933. |
this is a cross-sectional study of a non-probabilistic sample of 7405 brazilian adults (6620 [89.4%] cannabis users and 785 [10.6%] non-users) who answered an online survey that collected demographic data, cannabis and other substance use information (initial substance use, lifetime and past-month use), and standardized scales to assess quality of life, subjective well-being, anxiety, and depression scores. |
2021-12-22 |
2023-08-13 |
human |
| Paulo Rogério Morais, Kelsy Catherina Nema Areco, Thiago Marques Fidalgo, Dartiu Xavier da Silveir. Mental health and quality of life in a population of recreative cannabis users in Brazil. Journal of psychiatric research. vol 146. 2021-12-22. PMID:34936933. |
poor quality of life, depression or anxiety were more prevalent among dysfunctional users, but non-users of cannabis reported more depression or anxiety symptoms and less quality of life than both occasional and habitual users. |
2021-12-22 |
2023-08-13 |
human |